Explore

Streams

About Index

Index

By TNW

Thomas, McNerney & Partners

1268

Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development.

Follow us

Terms of Service Privacy Policy Cookie Statement

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 12

Portfolio

Portfolio Tracker

Zogenix Stock (ZGNX): $26 Price Target From Northland

,

Zogenix Stock (ZGNX): Why The Price Went Up Substantially Today

Invitae to buy health records startup Ciitizen for $325M

Report: Exact Sciences (EXAS) Approached Invitae (NVTA) For Merger Offer

Invitae Stock Price: $48 Target By Oppenheimer

Invitae Stock Price Increased Over 10% Pre-Market: Why It Happened

Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx

Invitae Acquires Diploid, Maker of Artificial–Intelligence Engine to Enable Clinical Diagnosis Using …

Invitae Acquires Diploid, Maker of Artificial–Intelligence Engine to Enable Clinical Diagnosis Using …

Invitae to buy VC-backed Jungla

FDA Refuses to Review Zogenix Seizure Drug, Says File Not Complete

$70,000,000 Venture capital

Intuity Medical Obtains $70M in Funding

Acquisition

J&J's Ethicon acquires Torax Medical

$20,000,000 Venture capital

Intuity Medical Nabs $20M In Credit Line

Acquisition

,

Invitae Expands Genome Network Via AltaVoice Acquisition

Torax Medical Raises $25M in Series E Funding

Health Funding

$25,000,000 Venture capital (Series E)

Torax Medical raises $25m

Invitae Scales Up DNA Test Offerings, Scores Mild Market Bump

Zogenix, Inc. Shares Galloped 15% Higher in February -- Here's Why

Health Stock markets

Zogenix, Inc Gained 29% in 2015 -- Here's Why --

Stock markets